Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
iShares US Medical Devices UCITS ETF USD (UMDV.AS)
About this ETF
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the Dow Jones U.S. Select Medical Equipment Capped 35/20 Index.
Price
Top 10 holdings
| ABBOTT LABORATORIES ABT | 16.90% |
| INTUITIVE SURGICAL INC ISRG | 14.88% |
| STRYKER CORP SYK | 11.75% |
| MEDTRONIC PLC 0Y6X.L | 11.12% |
| BOSTON SCIENTIFIC CORP BSX | 6.87% |
| EDWARDS LIFESCIENCES CORP EW | 5.48% |
| IDEXX LABORATORIES INC IDXX | 4.59% |
| BECTON DICKINSON BDX | 4.32% |
| RESMED INC RMD | 3.05% |
| GE HEALTHCARE TECHNOLOGIES INC GEHC | 3.04% |
Sector mix
Price chart
Returns
| 1 month | +3.81% |
| 3 months | -7.00% |
| 6 months | -18.92% |
| Year to date | -19.04% |
| 1 year | -16.95% |
| 3 years (ann.) | -2.86% |
| 5 years (ann.) | -3.19% |
| 10 years (ann.) | — |
Risk profile
| Volatility (1y, ann.) | 17.84% |
| Sharpe (1y) | -0.95 |
| Sharpe (3y) | -0.09 |
| Sortino (1y) | -1.60 |
| Max drawdown (1y) | -27.10% |
| Max drawdown (5y) | -31.57% |
| Max drawdown (full) | -31.57% |
| Beta vs S&P 500 (1y) | 0.23 |
| Correlation vs S&P 500 (1y) | 0.16 |
Technical outlook as of 2026-07-13
The Monte Carlo cone is drawn on the price chart above (Forecast overlay); RSI, MACD and the rest of the oscillators live in its indicator panels.
Full holdings
| Constituent | ISIN | Market value | Weight |
|---|---|---|---|
| Loading… | |||
Sector breakdown
Geographic exposure
Cost vs. peers
Comparison universe: 6,948 funds of the same asset class.
Cost impact calculator
Dividend history
Accumulating share class Income is reinvested inside the fund instead of being paid out. (inferred from the absence of distributions)
No distributions on record — accumulating share classes reinvest income instead of paying it out.
ESG profile
Benchmark: average of 4,066 funds of the same asset class with derived ESG data.
Similar ETFs
| Fund | TER | AUM (USD) | Yield (TTM) | Return 1y | Sharpe 1y |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF VTI | 0.03% | 2.30T | 1.05% | +19.93% | 1.48 |
| Vanguard S&P 500 ETF VOO | 0.03% | 1.70T | 1.07% | +19.68% | 1.49 |
| iShares Core S&P 500 ETF IVV | 0.03% | 894.38B | 1.09% | +19.68% | 1.49 |
| State Street SPDR S&P 500 ETF SPY | 0.09% | 789.23B | 1.00% | +19.71% | 1.49 |
| SPDR S&P 500 ETF Trust 1557.T | 0.09% | 789.09B | 0.49% | +37.54% | 2.26 |
| State Street SPDR S&P 500 ETF SPY.AX | 0.09% | 788.13B | 1.00% | +11.84% | 1.13 |
| Vanguard Total International Stock ETF VXUS | 0.05% | 652.30B | 2.61% | +20.58% | 1.21 |
| Invesco QQQ Trust, Series 1 QQQ | 0.18% | 481.14B | 0.43% | +28.14% | 1.43 |
| Vanguard Growth ETF VUG | 0.03% | 393.80B | 0.39% | +16.85% | 0.99 |
| Vanguard FTSE Developed Markets ETF VEA | 0.03% | 317.30B | 2.60% | +21.64% | 1.23 |
Cheaper alternatives
No fund of the class reaches 60% portfolio overlap — showing the cheapest funds of the class instead.
| Fund | TER | AUM (USD) | Overlap |
|---|---|---|---|
| Vanguard Mid-Cap ETF VO | 0.03% | 218.80B | 2.6% |
| iShares Core S&P 500 UCITS ETF CSPX.L | 0.07% | 151.69B | 1.4% |
| iShares Core S&P 500 UCITS ETF SXR8.DE | 0.07% | 151.54B | 1.4% |
| iShares Core S&P 500 UCITS ETF CSP1.L | 0.07% | 151.66B | 1.4% |
| iShares Core S&P 500 UCITS ETF CSSPX.MI | 0.07% | 151.54B | 1.4% |
